| MeSH term | MeSH ID | Detail |
|---|---|---|
| Inflammation | D007249 | 119 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Tibial Fractures | D013978 | 4 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Edlund A et al. | Myocardial ischaemia triggers formation of thromboxane. | 1987 | Lancet | pmid:2887865 |
| Gréen K and Vesterqvist O | In vivo synthesis of thromboxane A2 and prostaglandin I2 in healthy and diseased individuals. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959096 |
| Hamm CW et al. | Biochemical evidence of platelet activation in patients with persistent unstable angina. | 1987 | J. Am. Coll. Cardiol. | pmid:3668113 |
| Nowak J et al. | Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. | 1987 | Am. J. Physiol. | pmid:3548440 |
| Cibattoni G et al. | Effects of sulindac on renal and extrarenal eicosanoid synthesis. | 1987 | Clin. Pharmacol. Ther. | pmid:3549118 |
| Fitzgerald DJ et al. | Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. | 1987 | Circulation | pmid:3552297 |
| Vesterqvist O et al. | Thromboxane and prostacyclin formation in patients with deep vein thrombosis. | 1987 | Thromb. Res. | pmid:3554598 |
| Neiman J et al. | Effects of a small dose of ethanol and calcium carbimide-induced acetaldehyde intoxication on human platelet aggregation, associated thromboxane formation and urinary excretion of 2,3-dinor-6-keto prostaglandin F1 alpha. | 1987 | J. Toxicol. Clin. Toxicol. | pmid:3612897 |
| Neiman J et al. | Urinary excretion of 2, 3-dinor-6-keto prostaglandin F1 alpha and platelet thromboxane formation during ethanol withdrawal in alcoholics. | 1987 | J. Clin. Pathol. | pmid:3584500 |
| Förstermann U and Feuerstein TJ | Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. | 1987 | Clin. Sci. | pmid:3308287 |